Shang-Tseh Chou, Ph.D. - Related publications

2003 Harvard University, Cambridge, MA, United States 
Asia History
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2019 Wang J, Lu H, Wang W, Zheng N, Wang Y, Hu Z, Ji G. Hepatocyte Nuclear Factor 3β Plays a Suppressive Role in Colorectal Cancer Progression. Frontiers in Oncology. 9: 1096. PMID 31696055 DOI: 10.3389/fonc.2019.01096   
2019 Gao B, Zhao L, Wang F, Bai H, Li J, Li M, Hu X, Cao J, GuiYing W. Knockdown of ISOC1 inhibits the proliferation and migration and induces the apoptosis of colon cancer cells through the AKT/GSK-3β pathway. Carcinogenesis. PMID 31740942 DOI: 10.1093/carcin/bgz188   
2019 Deocesano-Pereira C, Machado RAC, De Jesus-Ferreira HC, Marchini T, Pereira TF, Carreira ACO, Sogayar MC. Functional impact of the long non-coding RNA deletion by CRISPR/Cas9 in the human triple negative metastatic Hs578T cancer cell line. Oncology Letters. 18: 5941-5951. PMID 31788068 DOI: 10.3892/ol.2019.10969   
2019 Nilsson MB, Le X, Heymach JV. β-Adrenergic Signaling in Lung Cancer: A Potential Role for Beta-Blockers. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 31828732 DOI: 10.1007/s11481-019-09891-w   
2019 Zeng X, Liu Q, Yang Y, Jia W, Li S, He D, Ma R. Placenta-specific protein 8 promotes the proliferation of lung adenocarcinoma PC-9 cells and their tolerance to an epidermal growth factor receptor tyrosine kinase inhibitor by activating the ERK signaling pathway. Oncology Letters. 18: 5621-5627. PMID 31620204 DOI: 10.3892/ol.2019.10911   
2019 Huang XH, Wang Y, Hong P, Yang J, Zheng CC, Yin XF, Song WB, Xu WW, Li B, He QY. Benzethonium chloride suppresses lung cancer tumorigenesis through inducing p38-mediated cyclin D1 degradation. American Journal of Cancer Research. 9: 2397-2412. PMID 31815042   
2019 Palechor-Ceron N, Krawczyk E, Dakic A, Simic V, Yuan H, Blancato J, Wang W, Hubbard F, Zheng YL, Dan H, Strome S, Cullen K, Davidson B, Deeken JF, Choudhury S, et al. Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks. Cells. 8. PMID 31717887 DOI: 10.3390/cells8111327   
2019 Ling B, Liao X, Huang Y, Liang L, Jiang Y, Pang Y, Qi G. Identification of prognostic markers of lung cancer through bioinformatics analysis and in vitro experiments. International Journal of Oncology. PMID 31789390 DOI: 10.3892/ijo.2019.4926   
2019 Men W, Li W, Li Y, Zhao J, Qu X, Li P, Gong S. RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma. Journal of Cancer. 10: 6278-6285. PMID 31772661 DOI: 10.7150/jca.35072   
2019 Mazzocchi A, Devarasetty M, Herberg S, Petty WJ, Marini F, Miller L, Kucera G, Dukes DK, Ruiz J, Skardal A, Soker S. Pleural Effusion Aspirate for use in 3D Lung Cancer Modeling and Chemotherapy Screening. Acs Biomaterials Science & Engineering. 5: 1937-1943. PMID 31723594 DOI: 10.1021/acsbiomaterials.8b01356   
2019 Gupta N, Park JE, Tse W, Low JK, Kon OL, McCarthy N, Sze SK. ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer. Oncotarget. 10: 5970-5982. PMID 31666928 DOI: 10.18632/oncotarget.27235   
2019 Agrawal S, Woźniak M, Łuc M, Makuch S, Pielka E, Agrawal AK, Wietrzyk J, Banach J, Gamian A, Pizon M, Ziółkowski P. Insulin enhancement of the antitumor activity of chemotherapeutic agents in colorectal cancer is linked with downregulating PIK3CA and GRB2. Scientific Reports. 9: 16647. PMID 31719636 DOI: 10.1038/s41598-019-53145-x   
2019 Ge JH, Zhu JW, Fu HY, Shi WB, Zhang CL. An Antisense Oligonucleotide Drug Targeting miR-21 Induces H1650 Apoptosis and Caspase Activation. Technology in Cancer Research & Treatment. 18: 1533033819892263. PMID 31818225 DOI: 10.1177/1533033819892263   
2019 Ge JH, Zhu JW, Fu HY, Shi WB, Zhang CL. An Antisense Oligonucleotide Drug Targeting miR-21 Induces H1650 Apoptosis and Caspase Activation. Technology in Cancer Research & Treatment. 18: 1533033819892263. PMID 31818225 DOI: 10.1177/1533033819892263   
2019 Park SH, Lee AR, Choi K, Joung S, Yoon JB, Kim S. TOMM20 as a Potential Therapeutic Target of Colorectal Cancer. Bmb Reports. PMID 31818360   
2019 Mulshine JL, Ujhazy P, Antman M, Burgess CM, Kuzmin I, Bunn PA, Johnson BE, Roth JA, Pass HI, Ross SM, Aldige CR, Wistuba II, Minna JD. From clinical specimens to human cancer preclinical models-a journey the NCI-cell line database-25 years later. Journal of Cellular Biochemistry. PMID 31803961 DOI: 10.1002/jcb.29564   
2019 Xue Q, Liu Z, Feng Z, Xu Y, Zuo W, Wang Q, Gao T, Zeng J, Hu X, Jia F, Zhu Y, Xia Y, Yu L. Penfluridol: An antipsychotic agent suppresses lung cancer cell growth and metastasis by inducing G0/G1 arrest and apoptosis. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 121: 109598. PMID 31733572 DOI: 10.1016/j.biopha.2019.109598   
2019 Xiao H, Xue Q, Zhang Q, Li C, Liu X, Liu J, Li H, Yang J. How Ginsenosides Trigger Apoptosis in Human Lung Adenocarcinoma Cells. The American Journal of Chinese Medicine. 1-18. PMID 31795742 DOI: 10.1142/S0192415X19500885   
2019 Peng X, Wen Y, Zha L, Zhuang J, Lin L, Li X, Chen Y, Liu Z, Zhu S, Liang J, Zhou Z, Yuan W, Li Y, Wang Y, Jiang Z, et al. TRIM45 Suppresses the Development of Non-small Cell Lung Cancer. Current Molecular Medicine. PMID 31663468 DOI: 10.2174/1566524019666191017143833   
2019 Maennling AE, Tur MK, Niebert M, Klockenbring T, Zeppernick F, Gattenlöhner S, Meinhold-Heerlein I, Hussain AF. Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials. Cancers. 11. PMID 31756933 DOI: 10.3390/cancers11121826   
2019 Liu Z, Cao H, Shi Y, Yang R. KIAA1211 plays an oncogenic role in human non-small cell lung cancer. Journal of Cancer. 10: 6747-6753. PMID 31777604 DOI: 10.7150/jca.35951   
2019 Roh JW, Choi JE, Han HD, Hu W, Matsuo K, Nishimura M, Lee JS, Kwon SY, Cho CH, Kim J, Coleman RL, Lopez-Bernstein G, Sood AK. Clinical and biological significance of expression in endometrial cancer. Cancer Biology & Therapy. 1-10. PMID 31640461 DOI: 10.1080/15384047.2019.1672455   
2019 Lian X, Xiang D, Peng C, Chen J, Liao M, Sun G, Zhang Z. DDX49 is a novel biomarker and therapeutic target for lung cancer metastases. Journal of Cellular and Molecular Medicine. PMID 31749282 DOI: 10.1111/jcmm.14734   
2019 Silva MM, Rocha CRR, Kinker GS, Pelegrini AL, Menck CFM. The balance between NRF2/GSH antioxidant mediated pathway and DNA repair modulates cisplatin resistance in lung cancer cells. Scientific Reports. 9: 17639. PMID 31776385 DOI: 10.1038/s41598-019-54065-6   
2019 Warchal SJ, Dawson JC, Shepherd E, Munro AF, Hughes RE, Makda A, Carragher NO. High content phenotypic screening identifies serotonin receptor modulators with selective activity upon breast cancer cell cycle and cytokine signaling pathways. Bioorganic & Medicinal Chemistry. 115209. PMID 31757681 DOI: 10.1016/j.bmc.2019.115209   
2019 Luzón-Toro B, Fernández RM, Martos-Martínez JM, Rubio-Manzanares-Dorado M, Antiñolo G, Borrego S. LncRNA LUCAT1 as a novel prognostic biomarker for patients with papillary thyroid cancer. Scientific Reports. 9: 14374. PMID 31591432 DOI: 10.1038/s41598-019-50913-7   
2019 Zhu Z, Yu Z, Rong Z, Luo Z, Zhang J, Qiu Z, Huang C. The novel GINS4 axis promotes gastric cancer growth and progression by activating Rac1 and CDC42. Theranostics. 9: 8294-8311. PMID 31754397 DOI: 10.7150/thno.36256   
2019 Neophytou CM, Kyriakou TC, Papageorgis P. Mechanisms of Metastatic Tumor Dormancy and Implications for Cancer Therapy. International Journal of Molecular Sciences. 20. PMID 31817646 DOI: 10.3390/ijms20246158   
2019 Zamulaeva IA, Selivanova EI, Matchuk ON, Krikunova LI, Mkrtchyan LS, Kulieva GZ, Kaprin AD. Quantitative Changes in the Population of Cancer Stem Cells after Radiation Exposure in a Dose of 10 Gy as a Prognostic Marker of Immediate Results of the Treatment of Squamous Cell Cervical Cancer. Bulletin of Experimental Biology and Medicine. PMID 31773353 DOI: 10.1007/s10517-019-04667-x   
2019 Chen HY, Li GH, Tan GC, Liang H, Lai XH, Huang Q, Zhong JY. Dexmedetomidine enhances hypoxia-induced cancer cell progression. Experimental and Therapeutic Medicine. 18: 4820-4828. PMID 31772647 DOI: 10.3892/etm.2019.8136   
2019 Yin H, Jiang Z, Wang S, Zhang P. Actinomycin D-Activated RNase L Promotes H2A.X/H2B-Mediated DNA Damage and Apoptosis in Lung Cancer Cells. Frontiers in Oncology. 9: 1086. PMID 31750234 DOI: 10.3389/fonc.2019.01086   
2019 Zhou DM, Liu J, Liu F, Luo GW, Li HT, Zhang R, Chen BL, Hua W. A novel FoxM1-PSMB4 axis contributes to proliferation and progression of cervical cancer. Biochemical and Biophysical Research Communications. PMID 31699366 DOI: 10.1016/j.bbrc.2019.10.183   
2019 Zhang WY, Liu QH, Wang TJ, Zhao J, Cheng XH, Wang JS. CircZFR serves as a prognostic marker to promote bladder cancer progression by regulating miR-377/ZEB2 signaling. Bioscience Reports. PMID 31746333 DOI: 10.1042/BSR20192779   
2019 Barbosa-Jobim GS, Costa-Lira É, Ralph ACL, Gregório L, Lemos TLG, Burbano RR, Calcagno DQ, Smith MAC, Montenegro RC, Vasconcellos MC. Biflorin inhibits the proliferation of gastric cancer cells by decreasing MYC expression. Toxicology in Vitro : An International Journal Published in Association With Bibra. 104735. PMID 31751609 DOI: 10.1016/j.tiv.2019.104735   
2019 Kim BK, Cheong JH, Im JY, Ban HS, Kim SK, Kang MJ, Lee J, Kim SY, Park KC, Paik S, Won M. PI3K/AKT/β-Catenin Signaling Regulates Vestigial-Like 1 Which Predicts Poor Prognosis and Enhances Malignant Phenotype in Gastric Cancer. Cancers. 11. PMID 31816819 DOI: 10.3390/cancers11121923   
2019 Ramirez-Peña E, Arnold J, Shivakumar V, Joseph R, Vidhya Vijay G, den Hollander P, Bhangre N, Allegakoen P, Prasad R, Conley Z, Matés JM, Márquez J, Chang JT, Vasaikar S, Soundararajan R, et al. The Epithelial to Mesenchymal Transition Promotes Glutamine Independence by Suppressing Expression. Cancers. 11. PMID 31652551 DOI: 10.3390/cancers11101610   
2019 Zhao L, Zhang J, Fan Y, Li Y. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 25: 7864-7871. PMID 31631173 DOI: 10.12659/MSM.917735   
2019 Yang X, Hu J, Shi C, Dai J. Activation of TGF-β1 Pathway by SCUBE3 Regulates TWIST1 Expression and Promotes Breast Cancer Progression. Cancer Biotherapy & Radiopharmaceuticals. PMID 31742430 DOI: 10.1089/cbr.2019.2990   
2019 Bharadwaj D, Mandal M. Senescence in polyploid giant cancer cells: A road that leads to chemoresistance. Cytokine & Growth Factor Reviews. PMID 31780423 DOI: 10.1016/j.cytogfr.2019.11.002   
2019 Guo Q, Zhu L, Wang C, Wang S, Nie X, Liu J, Liu Q, Hao Y, Li X, Lin B. SERPIND1 Affects the Malignant Biological Behavior of Epithelial Ovarian Cancer via the PI3K/AKT Pathway: A Mechanistic Study. Frontiers in Oncology. 9: 954. PMID 31637210 DOI: 10.3389/fonc.2019.00954   
2019 Martinez B, Yang Y, Harker DMR, Farrar C, Mukundan H, Nath P, Mascareñas D. YAP/TAZ Related BioMechano Signal Transduction and Cancer Metastasis. Frontiers in Cell and Developmental Biology. 7: 199. PMID 31637239 DOI: 10.3389/fcell.2019.00199   
2019 Chen L, Yang QC, Li YC, Yang LL, Liu JF, Li H, Xiao Y, Bu LL, Zhang WF, Sun ZJ. Targeting CMTM6 suppresses stem cell-like properties and enhances antitumor immunity in head and neck squamous cell carcinoma. Cancer Immunology Research. PMID 31771985 DOI: 10.1158/2326-6066.CIR-19-0394   
2019 Ghafouri-Fard S, Taheri M. UCA1 long non-coding RNA: An update on its roles in malignant behavior of cancers. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 120: 109459. PMID 31585301 DOI: 10.1016/j.biopha.2019.109459   
2019 Chen H, Yan S, Dong L, Li X. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer. Journal of Clinical Laboratory Analysis. e23061. PMID 31828834 DOI: 10.1002/jcla.23061   
2019 Ratnayake G, Shanker M, Roberts K, Mason R, Hughes BGM, Lwin Z, Jain V, O'Byrne K, Lehman M, Chua B. Prior or concurrent radiotherapy and nivolumab immunotherapy in non-small cell lung cancer. Asia-Pacific Journal of Clinical Oncology. PMID 31721446 DOI: 10.1111/ajco.13242   
2019 Hasegawa T, Ozaki Y, Inoue T, Watanabe Y, Fukuhara M, Yamaura T, Muto S, Okabe N, Higuchi M, Shio Y, Suzuki H. Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature. Journal of Medical Case Reports. 13: 316. PMID 31647029 DOI: 10.1186/s13256-019-2245-y   
2019 Li F, Li X, Li Z, Ji W, Lu S, Xia W. βKlotho is identified as a target for theranostics in non-small cell lung cancer. Theranostics. 9: 7474-7489. PMID 31695781 DOI: 10.7150/thno.35582   
2019 Li Y, Gan C, Zhang Y, Yu Y, Fan C, Deng Y, Zhang Q, Yu X, Zhang Y, Wang L, He F, Xie Y, Ye T, Yin W. Inhibition of Stat3 Signaling Pathway by Natural Product Pectolinarigenin Attenuates Breast Cancer Metastasis. Frontiers in Pharmacology. 10: 1195. PMID 31649548 DOI: 10.3389/fphar.2019.01195   
2019 Chopra N, Choudhury S, Bhargava S, Wajid S, Ganguly NK. Potentials of "stem cell-therapy" in pancreatic cancer: An update. Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]. PMID 31668563 DOI: 10.1016/j.pan.2019.09.016   
2019 Tang JC, Long F, Zhao J, Hang J, Ren YG, Chen JY, Mu B. The Effects and Mechanisms by which Saikosaponin-D Enhances the Sensitivity of Human Non-small Cell Lung Cancer Cells to Gefitinib. Journal of Cancer. 10: 6666-6672. PMID 31777595 DOI: 10.7150/jca.30361